Hangzhou Minsheng Healthcare Co., Ltd. (SHE:301507)
China · Delayed Price · Currency is CNY 11.84
+0.12 (1.02%)
At close: Sep 14, 2026
SHE:301507 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
| 4,154 | 5,477 | 4,525 | 5,883 | - | - | |
Market Cap Growth | -18.42% | 21.04% | -23.09% | - | - | - |
Enterprise Value | 3,469 | 4,611 | 3,652 | 4,951 | - | - |
Last Close Price | 11.72 | 15.17 | 12.44 | 16.04 | - | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
PE Ratio | 35.43 | 46.10 | 49.27 | 68.70 | - | - |
PS Ratio | 4.86 | 7.01 | 7.06 | 10.11 | - | - |
PB Ratio | 2.40 | 3.19 | 2.96 | 3.99 | - | - |
P/TBV Ratio | 2.84 | 3.79 | 3.03 | 4.11 | - | - |
P/FCF Ratio | - | - | 333.38 | 81.62 | - | - |
P/OCF Ratio | 24.16 | 30.91 | 41.72 | 54.40 | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 4.06 | 5.90 | 5.70 | 8.51 | - | - |
EV/EBITDA Ratio | 26.57 | 40.41 | 37.46 | 46.86 | - | - |
EV/EBIT Ratio | 34.07 | 52.92 | 48.63 | 62.66 | - | - |
EV/FCF Ratio | - | - | 269.06 | 68.69 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
Debt / EBITDA Ratio | 0.02 | 0.02 | 0.01 | 0.02 | 0.03 | 0.04 |
Debt / FCF Ratio | - | - | 0.08 | 0.03 | 0.05 | 0.19 |
Net Debt / Equity Ratio | -0.46 | -0.59 | -0.67 | -0.67 | -0.21 | -0.49 |
Net Debt / EBITDA Ratio | -6.22 | -8.89 | -10.60 | -9.30 | -1.15 | -2.76 |
Net Debt / FCF Ratio | 93.13 | 52.94 | -76.10 | -13.64 | -1.79 | -13.44 |
Asset Turnover | 0.42 | 0.42 | 0.38 | 0.48 | 0.76 | 0.72 |
Inventory Turnover | 6.07 | 3.67 | 2.73 | 2.11 | 2.04 | 1.85 |
Quick Ratio | 2.59 | 3.99 | 5.37 | 6.26 | 0.92 | 1.83 |
Current Ratio | 3.05 | 4.62 | 6.09 | 7.08 | 1.88 | 2.74 |
Return on Equity (ROE) | 7.15% | 7.45% | 6.11% | 8.29% | 14.25% | 14.60% |
Return on Assets (ROA) | 3.12% | 2.90% | 2.77% | 4.09% | 6.51% | 5.68% |
Return on Invested Capital (ROIC) | 9.62% | 12.76% | 13.14% | 14.54% | 18.41% | 19.18% |
Return on Capital Employed (ROCE) | 5.80% | 5.00% | 4.90% | 5.30% | 12.40% | 11.70% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Earnings Yield | 2.88% | 2.17% | 2.03% | 1.46% | - | - |
FCF Yield | -0.21% | -0.35% | 0.30% | 1.23% | - | - |
Dividend Yield | 1.22% | 0.99% | 0.80% | 0.62% | - | - |
Payout Ratio | 44.37% | 29.92% | 38.83% | - | - | 214.14% |
Buyback Yield / Dilution | -1.51% | -1.92% | -19.61% | -12.12% | -1.26% | -9.28% |
Total Shareholder Return | -0.29% | -0.93% | -18.81% | -11.50% | -1.26% | -9.28% |